DU-176b Phase III Clinical Study (Venous Thromboembolism) -A multicenter, Randomized, Unblinded Study of DU-176b in Patients Undergoing Hip Fracture Surgery with Enoxaparin as a reference
Phase 3
- Conditions
- Patients undergoing hip fracture surgery
- Registration Number
- JPRN-jRCT2080220770
- Lead Sponsor
- DAIICHISANKYO Co.,Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 90
Inclusion Criteria
Patients undergoing hip fracture surgery
Patients who are 20- years olds
Exclusion Criteria
Subjects with risks of hemorrhage
Subjects with thromboembolic risks
Subjects who weigh less than 40 kg
Subjects who are pregnant or suspect pregnancy, or subjects who want to become pregnant
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Proportion of subjects with bleeding events
- Secondary Outcome Measures
Name Time Method Proportion of subjects with venous thromboembolism events